Literature DB >> 17888840

The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study.

Anil Verma1, Nagesh S Anavekar, Alessandra Meris, Jens Jakob Thune, J Malcolm O Arnold, Jalal K Ghali, Eric J Velazquez, John J V McMurray, Marc A Pfeffer, Scott D Solomon.   

Abstract

OBJECTIVES: The purpose of this study was to determine whether alterations in cardiac structure or function contribute to the increased risk associated with renal impairment after myocardial infarction (MI).
BACKGROUND: Renal impairment is associated with adverse cardiovascular outcomes after MI.
METHODS: Echocardiography was performed on 603 patients with left ventricular (LV) dysfunction, heart failure (HF), or both after MI. Patients were grouped according to their estimated glomerular filtration rate (eGFR), and measures of cardiac structure and function were related to baseline eGFR. The relationship between eGFR and cardiac structure and function and clinical outcomes of death or HF was assessed with multivariable Cox regression.
RESULTS: Ejection fraction, infarct segment length, right ventricular function, and mitral deceleration time were not influenced by renal function. Patients with reduced eGFR had smaller LV and larger left atrial (LA) volumes and higher left ventricular mass index (LVMI) and LV mass/LV volume ratio. A greater proportion of the patients with reduced eGFR had LV hypertrophy. The relationship between eGFR and the outcome of death or HF was attenuated by including baseline differences in LVMI, and both LVMI and LA volume conferred additional prognostic information in a multivariable model.
CONCLUSIONS: Renal impairment was associated with smaller LV and larger LA volumes and increased LVMI. Systolic function was similar when compared with patients with normal renal function. Thus, reduced systolic function cannot account for worse outcomes in patients with renal impairment after MI. Indirect measures of diastolic function suggest that diastolic dysfunction might be an important mediator of increased risk in this population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17888840     DOI: 10.1016/j.jacc.2007.06.018

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  22 in total

1.  Reduced renal function is associated with combined increases in ventricular-systolic stiffness and arterial load in patients undergoing cardiac catheterization for coronary artery disease.

Authors:  Hidekatsu Fukuta; Nobuyuki Ohte; Kazuaki Wakami; Kaoru Asada; Toshihiko Goto; Seiji Mukai; Genjiro Kimura
Journal:  Heart Vessels       Date:  2010-10-16       Impact factor: 2.037

2.  Left-ventricular systolic and diastolic dyssynchrony as assessed by multi-harmonic phase analysis of gated SPECT myocardial perfusion imaging in patients with end-stage renal disease and normal LVEF.

Authors:  Ji Chen; Andreas P Kalogeropoulos; Liudmila Verdes; Javed Butler; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2011-01-13       Impact factor: 5.952

3.  Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction.

Authors:  Mauro Gori; Michele Senni; Deepak K Gupta; David M Charytan; Elisabeth Kraigher-Krainer; Burkert Pieske; Brian Claggett; Amil M Shah; Angela B S Santos; Michael R Zile; Adriaan A Voors; John J V McMurray; Milton Packer; Toni Bransford; Martin Lefkowitz; Scott D Solomon
Journal:  Eur Heart J       Date:  2014-06-30       Impact factor: 29.983

4.  Diastolic dysfunction predicts the risk of contrast-induced nephropathy and outcome post-emergency percutaneous coronary intervention in AMI patients with preserved ejection fraction.

Authors:  Beibei Han; Yongguang Li; Zhifeng Dong; Qing Wan; Hong Shen; Jingbo Li; Meng Wei; Chengxing Shen
Journal:  Heart Vessels       Date:  2018-04-27       Impact factor: 2.037

5.  Renal impairment and heart failure with preserved ejection fraction early post-myocardial infarction.

Authors:  Vinod Jorapur; Gervasio A Lamas; Zygmunt P Sadowski; Harmony R Reynolds; Antonio C Carvalho; Christopher E Buller; James M Rankin; Jean Renkin; Philippe Gabriel Steg; Harvey D White; Carlos Vozzi; Eduardo Balcells; Michael Ragosta; C Edwin Martin; Vankeepuram S Srinivas; William W Wharton Iii; Staci Abramsky; Ana C Mon; Shari S Kronsberg; Judith S Hochman
Journal:  World J Cardiol       Date:  2010-01-26

Review 6.  Can we prevent or treat renal dysfunction in chronic heart failure?

Authors:  Daniela Dobre; Patrick Rossignol; Marco Metra; Faiez Zannad
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

Review 7.  Influence of chronic kidney disease on cardiac structure and function.

Authors:  Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

8.  Impaired leukocytes autophagy in chronic kidney disease patients.

Authors:  Wei-Ting Chen; Kuo-Chun Hung; Ming-Shien Wen; Po-Yaur Hsu; Tien-Hsing Chen; Horng-Dar Wang; Ji-Tseng Fang; Shian-Sen Shie; Chao-Yung Wang
Journal:  Cardiorenal Med       Date:  2013-11-01       Impact factor: 2.041

9.  Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.

Authors:  Orlando M Gutiérrez; James L Januzzi; Tamara Isakova; Karen Laliberte; Kelsey Smith; Gina Collerone; Ammar Sarwar; Udo Hoffmann; Erin Coglianese; Robert Christenson; Thomas J Wang; Christopher deFilippi; Myles Wolf
Journal:  Circulation       Date:  2009-05-04       Impact factor: 29.690

10.  Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study.

Authors:  Jehu Mathew; Ronit Katz; Martin St John Sutton; Sanjay Dixit; Edward P Gerstenfeld; Stefano Ghio; Michael R Gold; Cecilia Linde; Michael G Shlipak; Rajat Deo
Journal:  Eur J Heart Fail       Date:  2012-09-06       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.